The U.S. Food and Drug Administration has designated SetPoint Medical’s neurostimulator a breakthrough device for the treatment of relapsing-remitting multiple sclerosis (RRMS).
This designation is intended to accelerate the development of devices intending to more effectively treat or diagnose life-threatening or chronically debilitating diseases than standard approaches.
It was supported by evidence showing that SetPoint’s nerve stimulator platform may slow myelin damage and promote its repair, an unmeet need in multiple sclerosis (MS) and other demyelinating conditions. The company now is planing to work with the regulatory agency to open a clinical trial of the therapeutic device in RRMS patients.
https://multiplesclerosisnewstoday.com/ ... WToJ2giAHz
Neurostimulator to repair myelin in RRMS
-
- Similar Topics
- Replies
- Views
- Last post
-
- 6 Replies
- 1816 Views
-
Last post by NHE
-
- 1 Replies
- 1821 Views
-
Last post by val57gal
-
- 0 Replies
- 1744 Views
-
Last post by NHE
-
- 0 Replies
- 2529 Views
-
Last post by NHE
-
- 0 Replies
- 2283 Views
-
Last post by DIM
-
- 2 Replies
- 1675 Views
-
Last post by jimmylegs
-
- 40 Replies
- 7592 Views
-
Last post by ElliotB
-
- 0 Replies
- 1766 Views
-
Last post by frodo
-
- 3 Replies
- 1136 Views
-
Last post by Scott1